Insights

Enterprise acquisition Basepaws was acquired by Zoetis in June 2022, positioning the genetic testing capabilities within a larger animal health portfolio. Sales opportunities exist in cross-selling advanced pet health diagnostics and integration with Zoetis’ existing veterinary networks and distribution channels.

Direct-to-consumer expansion The company has launched and planned further direct-to-consumer DNA tests for dogs and cats, with multi-channel availability (website, Amazon, and other consumer channels). This creates opportunities to partner on marketing corridors, fulfillment, and data-driven consumer education programs.

Vet network tools Basepaws has rolled out genetic and oral microbiome screening tools for veterinary teams. There is potential to upsell expanded panels, subscription-based screening updates, and training services to veterinary clinics and hospital partners.

Early detection focus With emphasis on early health risk detection through genetics and microbiome data, there are sales paths for larger clinics or insurers seeking proactive care programs, risk stratification services, and integration with electronic medical records for outcome tracking.

Global pet health trend The market trend toward precision pet health and cat/dog DNA insights aligns with Zoetis’ broader portfolio. Opportunities exist to scale through co-branded campaigns, data analytics services, and expanded test offerings in regions with growing pet ownership and premium care demand.

Similar companies to Basepaws

Basepaws Tech Stack

Basepaws uses 8 technology products and services including Criteo, Reddit Ads, Power BI, and more. Explore Basepaws's tech stack below.

Media & News

Basepaws's Email Address Formats

Basepaws uses at least 2 email formats:
Basepaws Email FormatsExamplePercentage
First@basepaws.comJohn@basepaws.com
71%
First.Last@basepaws.comJohn.Doe@basepaws.com
29%

Frequently Asked Questions

What is Basepaws's official website and social media links?

Minus sign iconPlus sign icon
Basepaws's official website is basepaws.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Basepaws generate?

Minus sign iconPlus sign icon
As of October 2026, Basepaws's annual revenue is estimated to be $1M - $10M.

What is Basepaws's SIC code and NAICS code?

Minus sign iconPlus sign icon
Basepaws's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Basepaws have currently?

Minus sign iconPlus sign icon
As of October 2026, Basepaws has approximately 17 employees across 3 continents, including North America, South America and Europe. Key team members include Operations Manager: P. S., Leader Software Engineer: D. L. and Veterinary Advisory Board Member: L. S. Explore Basepaws's employee directory with LeadIQ.

What industry does Basepaws belong to?

Minus sign iconPlus sign icon
Basepaws operates in the Biotechnology Research industry.

What technology does Basepaws use?

Minus sign iconPlus sign icon
Basepaws's tech stack includes Criteo, Reddit Ads, Power BI, Tableau, Google Cloud, HubSpot, Amazon Pay and Piwik.

What is Basepaws's email format?

Minus sign iconPlus sign icon
Basepaws's email format typically follows the pattern of First@basepaws.com. Find more Basepaws email formats with LeadIQ.

How much funding has Basepaws raised to date?

Minus sign iconPlus sign icon
As of October 2026, Basepaws has raised $251K in funding. The last funding round occurred on Jan 01, 2023.

When was Basepaws founded?

Minus sign iconPlus sign icon
Basepaws was founded in 2017.
Basepaws logo

Basepaws

Biotechnology ResearchCalifornia, United States11-50 Employees

Basepaws is a biotechnology research company focused on companion animal health, developing early-detection tests built from genetic and microbiome data. It operates what has been described as the world’s first at-home genetic testing platform for cats, offering insights into breed and health traits. The firm was founded in 2017 by Anna Skaya and is based in Los Angeles, California. In 2022, Zoetis completed its acquisition of Basepaws, integrating the business into its precision animal health portfolio. The company has expanded its product line to include Breed + Health tests for dogs, with a dog DNA test launched in 2023.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $251K

    Basepaws has raised a total of $251K of funding over 7 rounds. Their latest funding round was raised on Jan 01, 2023 as a Venture Round.

  • $1M - $10M

    Basepaws's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.